CTLA (Abatacept) Prevention (TN18)
Abatacept is given as an investigational study drug to relatives of someone with type 1 diabetes who have positive diabetes antibodies in an attempt to prevent or delay the onset of type 1 diabetes. See TrailNet.org - Opens in a new window website for more details.